These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3401892)

  • 41. Cardiocirculatory effects of nitrates in the treatment of clinical congestive heart failure.
    Mason DT; Awan NA; DeMaria AN; Lee G; Amsterdam EA
    Herz; 1978 Dec; 63(36):387-98. PubMed ID: 400159
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes of the systolic variations of the left ventricle induced by isosorbitol dinitrate in patients with chronic coronary insufficiency].
    Savioli RM; Del Nero E; Ortiz J; Rangel FA; Barretto AC; Papaléo Netto M; Diament J; Tranchesi J
    Arq Bras Cardiol; 1977 Dec; 30(6):441-4. PubMed ID: 614003
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 44. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
    Stephens JD; Marks C; Woodings D; Vandenburg MJ
    Cardiology; 1987; 74 Suppl 1():69-71. PubMed ID: 3607807
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of isosorbide-5-mononitrate in acute myocardial infarction].
    Piegas LS; Timerman S; Timerman A; Gun C; Ramos RF; Romano ER; De Magalhães HM; Sousa JE
    Arq Bras Cardiol; 1989 Mar; 52(3):167-72. PubMed ID: 2597005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative hemodynamic study of IS-5-MN and ISDN in man--which are equieffective doses?
    Vogt A; Bernhardt S; Schwarck H; Stroh E; Kreuzer H
    Z Kardiol; 1983; 72 Suppl 3():182-4. PubMed ID: 6666220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
    Stauch M; Grewe N
    Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
    [No Abstract]   [Full Text] [Related]  

  • 49. [Long-term haemodynamic effect of high doses of isosorbid dinitrate (80 mg) in slow-release form in coronary heart disease (author's transl)].
    Wolf R; Sinn R; Guillen R; Koeffler H
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1130-4. PubMed ID: 7261938
    [No Abstract]   [Full Text] [Related]  

  • 50. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
    Kayali A
    Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of parasympathetic blockade on ischemic threshold in patients with exercise-induced myocardial ischemia.
    Marraccini P; Orsini E; Nassi G; L'Abbate A
    Am J Cardiol; 1991 Aug; 68(5):539-42. PubMed ID: 1872284
    [No Abstract]   [Full Text] [Related]  

  • 52. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect].
    Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH
    Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The duration of th effect of isosorbide-5-mononitrate--a new anti-anginal agent].
    Kozák P
    Vnitr Lek; 1985 Dec; 31(12):1217-21. PubMed ID: 4090311
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):361-77. PubMed ID: 791567
    [No Abstract]   [Full Text] [Related]  

  • 55. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
    Pascal N; Eggert R
    Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
    Uberbacher HJ; Glocke M; Abshagen U
    MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
    Schiavoni G; Bosimini E; Amico C
    Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparison of the effectiveness of olicard 40 retard and cardonit 40 prolongatum preparations in treatment of stable coronary heart disease].
    Kurpesa M; Krzemińska-Pakuła M; Kedzia E; Trzos E; Musiał W; Peruga Z
    Wiad Lek; 1994 Aug; 47(15-16):587-90. PubMed ID: 7716955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
    Caponnetto S; Canale C; Terrachini V; Masperone MA
    Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.